Table 3.

Diagnostic ability of the four new criteria with a serum AMH cutoff value of 3.8 ng/mL among the patients diagnosed with PCOS according to each of the present diagnostic criteria

		Sensitivity%	Specificity%	AUC	p
Rotterdam	AMH and OA	69	99	0.85 (0.84–0.88)	<0.001
	AMH and HA	73	99	0.86 (0.83–0.89)	<0.001
	AMH and (OA or HA)	83	100	0.92 (0.88–0.94)	<0.001
	Two of (AMH/OA/HA)	96	100	0.97 (0.96–0.99)	<0.001
Androgen Excess Society	AMH + OA	67	93	0.80 (0.76–0.85)	<0.001
	AMH + HA	83	98	0.90 (0.87–0.94)	<0.001
	AMH + (OA or HA)	83	93	0.87 (0.84–0.90)	<0.001
	Two of (AMH/OA/HA)	96	93	0.95 (0.92–0.97)	<0.001
National Institutes of Health	AMH + OA	79	94	0.86 (0.82–0.90)	<0.001
	AMH + HA	83	93	0.88 (0.84–0.92)	<0.001
	AMH + (OA or HA)	83	88	0.86 (0.82–0.89)	<0.001
	Two of (AMH/OA/HA)	100	88	0.94 (0.92–0.96)	<0.001

OA oligo/amenorrhea, HA hyperandrogenism